Wordt geladen...

Current treatment of atypical hemolytic uremic syndrome

Tremendous advances have been made in understanding the pathogenesis of atypical Hemolytic Uremic Syndrome (aHUS), an extremely rare disease. Insights into the molecular biology of aHUS resulted in rapid advances in treatment with eculizumab (Soliris(®), Alexion Pharmaceuticals Inc.). Historically,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Kaplan, Bernard S., Ruebner, Rebecca L., Spinale, Joann M., Copelovitch, Lawrence
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: International Research and Cooperation Association for Bio & Socio-Sciences Advancement 2014
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4204535/
https://ncbi.nlm.nih.gov/pubmed/25343125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2014.01001
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!